Organozen Redefining API Mfg in Telangana with a 30 Crore

Organozen Chemicals Private Limited is set to revolutionize pharmaceutical manufacturing with its Active Pharmaceuticals Ingredients (API) Manufacturing Unit in Talmadla, Kamareddy, Telangana, investing 30 Crores in this endeavor. Spanning 2.13 hectares, this forward-thinking project outlines a water usage strategy aiming for a total consumption of 171.7 KLD, balancing 130.1 KLD of fresh water intake with a commendable 41 KLD recycled after treatment from their ETP-ZLD, demonstrating a commitment to sustainable water practices.

Despite promising potential, crucial details regarding the project's environmental impact assessment, specific API focus, employment generation, and project timeline remain undisclosed. Addressing waste management, emissions control, and embracing sustainable methodologies are vital for Organozen Chemicals to align with environmental regulations. Moreover, the clarity on API specifics and the projected employment opportunities would provide a clearer understanding of the project's scope and impact. A defined timeline would offer stakeholders insights into the project's development trajectory.

Overall, while the project signifies a positive stride for Organozen Chemicals and the region, additional information on environmental compliance, targeted API production, employment prospects, and project timelines would substantiate its potential and contributions to the pharmaceutical landscape.

As on January, 2024. Project building has begun. 65% of the project is done. The project will finish in December 2024.

News by Rahul Yelligetti